DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 4Dr. Reddy's Laboratories
02 8Accord healthcare
03 4Adalvo
04 1Aurobindo Pharma Limited
05 27Boehringer Ingelheim GmbH
06 4CLONMEL HLTHCARE
07 2Captavis Biocare
08 1Cipla
09 2Cipla Medpro South Africa
10 2Eignapharma S.L.
11 2Eignapharma Sl
12 2Eugia Pharma
13 1Glenmark Pharmaceuticals
14 2Intas Pharmaceuticals
15 4Lotus Pharma Bulgaria Eood
16 6Lotus Pharmaceutical
17 2Newbury Pharmaceuticals Ab
18 2Olon S.p.A
19 4STADA Arzneimittel
20 4Sandoz B2B
21 6Teva Pharmaceutical Industries
22 2Zentiva
01 4CAP
02 5CAPSULE
03 8CAPSULE;ORAL
04 27Capsule
05 5Capsule, soft
06 1Nintedanib 100Mg 60 Units Oral Use
07 1Nintedanib 150Mg 60 Units Oral Use
08 2Oral Solid Dosage Form
09 31Soft Capsule
10 2Soft Gel
11 2Soft Gelatin Capsule
12 4Blank
01 25Approved
02 12Authorised
03 19Authorized
04 1Available Dossier- US-EU-RoW
05 2Generic
06 2Lead Market Dossiers- Under Development
07 2Originator
08 2Prescription
09 2RX
10 25Blank
01 2Lunidoc
02 9NINTEDANIB
03 4Nifibro
04 2Nifiden
05 1Nintedanib 100 mg Cipla
06 1Nintedanib 150 mg Cipla
07 4Nintedanib Accord
08 2Nintedanib Accordpharma
09 2Nintedanib Clonmel
10 2Nintedanib Clonmel Healthcare
11 4Nintedanib Eignapharma
12 2Nintedanib Eugia
13 4Nintedanib Lotus
14 2Nintedanib Newbury
15 2Nintedanib Reddy
16 4Nintedanib Sandoz
17 4Nintedanib Stada
18 4Nintedanib Teva
19 2Nintedanib Zentiva
20 4OFEV
21 14Ofev
22 1Ofev 100 mg
23 1Ofev 150 mg
24 5Vargatef
25 2Wolff
26 8Blank
01 4Australia
02 2Canada
03 6India
04 4Italy
05 12Malta
06 5Norway
07 4South Africa
08 19Spain
09 25Sweden
10 11USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Under Development
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Nintedanib Reddy
Dosage Form : Capsule
Dosage Strength : 100mg
Packaging :
Approval Date : 12/06/2025
Application Number : 20240229000113
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Nintedanib Reddy
Dosage Form : Capsule
Dosage Strength : 150mg
Packaging :
Approval Date : 12/06/2025
Application Number : 20240229000120
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date :
Application Number : 212732
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date :
Application Number : 212732
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date :
Application Number : 215123
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OFEV
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2014-10-15
Application Number : 205832
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : OFEV
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date : 2014-10-15
Application Number : 205832
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Italy
Brand Name : Ofev
Dosage Form : Nintedanib 100Mg 60 Units Oral Use
Dosage Strength : 1x60 soft cps 100 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Ofev
Dosage Form : Nintedanib 150Mg 60 Units Oral Use
Dosage Strength : 1x60 soft cps 150 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Norway
Brand Name : Ofev
Dosage Form : Capsule, soft
Dosage Strength : 100 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Ofev
Dosage Form : Capsule, soft
Dosage Strength : 150 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Vargatef
Dosage Form : Capsule, soft
Dosage Strength : 100 mg
Packaging : Blister
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 212609
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 150MG BASE
Packaging :
Approval Date :
Application Number : 212555
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 216915
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number : 216915
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 219371
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : NINTEDANIB
Dosage Form : CAPSULE
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number : 219371
Regulatory Info :
Registration Country : USA
